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Abstract
Background: In Brazil, malaria is endemic in the Amazon River basin and non-endemic in the extra-Amazon region,
which includes areas of São Paulo state. In this state, a number of autochthonous cases of malaria occur annually,
and the prevalence of subclinical infection is unknown. Asymptomatic infections may remain undetected, maintaining
transmission of the pathogen, including by blood transfusion. In these report it has been described subclinical
Plasmodium infection in blood donors from a blood transfusion centre in São Paulo, Brazil.
Methods: In this cross-sectional study, representative samples of blood were obtained from 1,108 healthy blood
donors at the Fundação Pró-Sangue Hemocentro de São Paulo, the main blood transfusion centre in São Paulo.
Malaria exposure was defined by the home region (exposed: forest region; non-exposed: non-forest region).
Real-time PCR was used to detect Plasmodium falciparum and Plasmodium vivax. Subclinical malaria cases were
geo-referenced.
Results: Eighty-four (7.41%) blood donors tested positive for Plasmodium; 57 of these were infected by P. falciparum,
25 by P. vivax, and 2 by both. The prevalence of P. falciparum and P. vivax was 5.14 and 2.26, respectively. The overall
prevalence ratio (PR) was 3.23 (95% confidence interval (CI) 2.03, 5.13); P. falciparum PR was 16.11 (95% CI 5.87, 44.21) and
P. vivax PR was 0.47 (95% CI 0.2, 1.12). Plasmodium falciparum subclinical malaria infection in the Atlantic Forest domain
was present in the mountain regions while P. vivax infection was observed in cities from forest-surrounded areas.
Conclusions: The presence of Plasmodium in healthy blood donors from a region known as non-endemic, which is
important in the context of transfusion biosafety, was described. Infected recipients may become asymptomatic carriers
and a reservoir for parasites, maintaining their transmission. Furthermore, P. falciparum PR was positively associated with
the forest environment, and P. vivax was associated with forest fragmentation.
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Background
In Brazil, human malaria is mainly caused by Plasmo-
dium vivax, which accounts for more than 80% of iden-
tified cases; Plasmodium falciparum is responsible for
16.3%, and Plasmodium malariae is associated with a small
number of cases [1,2]. The majority of malaria is reported
in the Brazilian Amazon region [3] where Anopheles dar-
lingi is the primary vector in recently deforested areas [4].
The annual parasite index is typically employed to esti-
mate the risk of occurrence of malaria in human popula-
tions that are exposed to infective Anopheles mosquito
bites, in a specific time frame. In endemic regions, this
index is spatially and temporarily variable, and its values
can be low (0.1–9.9), moderate (10.0–49.9), or high (>50)
[3], depending on ecological and environmental determi-
nants that represent distinct risk in different social and
economic contexts [5]. Areas of high endemicity have an
elevated prevalence of individuals with subclinical infec-
tions [6]. In the Amazon region of Brazil, studies per-
formed in Amerindians [7] and in riverine communities [8]
in the state of Rondônia have shown the presence of long-
term subclinical infections. Those individuals were infected
with Plasmodium spp; however, most of them showed low
levels of parasitaemia [9]. Subclinical infections also have
been found in meso- and hypo-endemic regions [8,10,11].
The São Paulo municipality and nearby areas in southeast-
ern Brazil are considered non-endemic regions; however,
in 2013, 146 autochthonous cases of malaria were identi-
fied in São Paulo State, representing 22% of the total occur-
ring outside the Amazon region. Moreover, there was a
256% increase compared to 2006 [12].
Plasmodium pathogens that cause malaria in humans
are naturally transmitted by infectious Anopheles mosquito
bites [13]. However, the protozoan can be accidentally
transmitted by blood transfusion [14] and intravenous
drug users [10]. The first case of transfusional malaria
was registered in 1911 [15-17]. Although uncommon,
transfusional malaria can have serious clinical implica-
tions when undetected and not treated early [18,19]. In
the Amazon State, 0.3% of screened blood donors were
found to be infected with P. vivax [20] when the diag-
noses were based on an especially sensitive molecular
probe, i.e., PCR technology. In Brazil, the laws govern-
ing the screening obligation for Plasmodium infection
in blood donors from an endemic region are distinct
from those adopted in non-endemic areas [21]. Further-
more, in non-endemic areas, all candidates for blood
donation are subjected to an interview before they donate
blood. Following the interview, potential blood donors
can be either rejected or accepted for donation, without
enforcement for a laboratorial screening for Plasmodium
infection [21]. Considering both the circulation of Plas-
modium spp. in non-endemic areas and the fact that
there is no obligation for screening for Plasmodium, it is
plausible to suppose that accidental transfusional Plas-
modium transmission can occur, mainly by the presence
of subclinical infection in humans.
Transfusion-transmitted Plasmodium parasites repre-
sent an important risk factor because they can cause se-
vere malaria with a high fatality rate [22]. The chronic
infection can persist in humans for a long period of
time: up to two years or more for P. falciparum, up to
seven years for P. vivax, and even for an entire lifetime
for P. malariae [1]. Consequently, an asymptomatic hu-
man who is unaware of his/her status as a Plasmodium
reservoir can transmit the parasites when donating blood.
Usually, parasite concentration is low in asymptomatic
individuals [8]; however, asymptomatic humans can both
infect Anopheles females [9] and cause severe infection in
blood recipients [22].
Employing a high sensitivity real-time PCR in a cross-
sectional design, it was addressed 1) the prevalence of
P. falciparum and P. vivax among blood donors at a
public blood bank in the municipality of São Paulo,
Brazil; 2) the spatial distribution of the blood donors;
and 3) the potential association between the geograph-
ical origins of donors and the Plasmodium species.
Methods
Participants and samples
A cross-sectional study was adopted with the main ob-
jective of estimating the prevalence of subclinical malar-
ial infections among blood donors in the State of São
Paulo. The studied population was composed of 1,108
blood donors enrolled at the Fundação Pró-Sangue
Hemocentro de São Paulo, Brazil, from August 2008 to
March 2010. The sampling procedure employed a non-
probabilistic cumulative method. Accordingly, individuals
who came to donate blood were cumulatively selected re-
garding free potentially past/recent malarial infections as
inclusion criteria. Each blood donor volunteer was inter-
viewed for previous malaria, location of residence, and
travel/visit to endemic regions. Brazilian guidelines rec-
ommend refusing as a potential blood donor any individ-
ual who has lived in a malaria-endemic region within the
past three years as well as those who have travelled to
those areas in the past six months. Consequently, the
present study does not include individuals who were
rejected for blood donation based on these conditions. In
terms of sampling procedure, it was knew who would be
next to donate blood nor who would be included in the
study. This circumstance made the sampling procedure
random, which is a reasonable proxy for obtaining a rep-
resentative sample of blood donors from the population
in the State of São Paulo [23].
To calculate the sample size, the prior prevalence of
subclinical malarial infections among blood donors was
considered to be 1%. This subclinical malaria information
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is unavailable for the State of São Paulo, and the sample
size for the cross-sectional study thus was estimated using
Plasmodium spp. prevalence (1.3%) in blood banks in the
State of Amazon [3]. Considering that prevalence was pre-
sumed as 0.01, standard error was tolerable at 0.02, and
95% confidence intervals were selected and applied. The
following statistical equation of minimum sample size cal-
culation for prevalence data was used:
n ¼ z2α
2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P 1−Pð Þp
ε2
where n* =minimum sample size; z = critical percentile
of the z distribution (1.96); α = significance level (0.05);
ε = standard error or tolerable error (0.02 or 2%), which
measures discrepancy between population prevalence
(unknown) and estimated prevalence from the obtained
sample; and P = prior prevalence data (as supported by
[24-26]). Based on the values obtained in the sample size
estimation, the study had to include blood from at least
956 individuals to estimate the prevalence of malarial in-
fections among blood donors with a confidence interval
of 95% and precision of 2%.
Once the representative sample (N) was obtained, four
groups were defined: disease-exposed (a), non-disease
exposed (b), disease non-exposed (c), and non-disease
non-exposed (d). Exposure status was defined based on
evidence of risk of being in contact with infectious mos-
quito bites (e.g., location of residence that may indicate
the presence of Anopheles mosquito vectors). Individuals
living in forested areas of the Atlantic Forest were con-
sidered at risk of infection whereas those from urban
areas in the Metropolitan Region of São Paulo were con-
sidered to be without risk of malaria (Figure 1). No indi-
vidual had fever or evident signs of infection at the time
of the blood donation; thus, disease and non-disease
status were evaluated using real-time PCR. Peripheral
venous blood (5 mL) was drawn from the volunteers
and screened for P. falciparum and P. vivax by real-time
PCR.
Each volunteer was informed about the research and
research procedures before signing written informed
consent. Both protocol and procedures employed in the
present study were approved by the Research Ethics Com-
mittee of the institution.
Plasmodium identification by real-time PCR
DNA was extracted from blood samples using a salting-
out method with slight modifications [27,28]. DNA in-
tegrity was analysed by agarose gel electrophoresis, and
the concentration was determined with a nanoDrop
ND-1000 spectrophotometer (USA) [29]. Samples of
P. falciparum and P. vivax were used as positive control
for the real-time PCR protocol.
RT-PCR was performed following the protocol de-
scribed by Gama et al. [30]. Two-hundred ng of DNA
were added to a 12.5 μL reaction mixture containing 1X
TaqMan Universal PCR Master Mix (Applied Biosystems,
Foster City, CA, USA) with 500 mM of each dNTP. The
primers and probe sequences employed are listed in
Additional file 1. Each sample was analysed in duplicate.
Real-time PCR amplification was performed in a Rotor
Gene 3000 (Corbett Research, San Francisco, CA, USA)
using a program involving two thermal cycler holds
(50°C for 2 min and 95°C for 10 min), followed by 45 cycles
of amplification (95°C for 15 s, 52°C for 60 s, and 72°C for
60 s). Results were automatically analysed using real-time
Rotor Gene 6 software.
The efficiency and sensitivity of the real-time PCR
protocol were examined using genomic DNA extracted
from lab-cultured P. falciparum parasites, and P. vivax
Figure 1 Study System: South America, Brazil, São Paulo State.
Exposure status was defined by considering the presence/absence
of forested regions in the State of São Paulo. Forested regions are
localized in the southeast of the State of São Paulo and represent
remnants of the Atlantic rainforest.
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from the blood of humans with a confirmed diagnosis
of vivax malaria. A standard curve was constructed for
each Plasmodium species from a 10-fold serial dilution
of parasite DNA, ranging from 106 to 0.1 copies/μL. The
threshold limits were automatically set for each reaction,
and mean Ct was calculated for each amplified triplicate.
Amplification efficiencies for the different primer pairs
and probes were calculated with the following formula:
Efficiency = 10(−1/Slope) − 1 (Additional file 1). Samples
were considered positive when the amplification curves
reached the threshold line. A positive PCR assay was
demonstrated at 0.00001% parasitaemia (0.5 parasite/μL)
for all Plasmodium species.
To evaluate the intra- and inter-assay Ct variation of
real-time PCR, we analyzed the coefficient of variation
of DNA parasite samples in triplicate and in the blood
samples showing low parasitaemia. Pure parasite DNA
showed a Ct coefficient of 0.1 while the Ct coefficient
was 0.3 among low-parasitized blood samples. The Ct
values were the same and stable for each DNA parasite
sample in different experiments.
No cross-amplification between different reactions was
observed. A PCR amplification product was obtained
only when specific Plasmodium species were present in
the reaction; no PCR product was detected in samples
without specific parasites.
Data analysis
In this cross-sectional study, the starting point was a
representative sample (N) obtained for defining the four
groups under study (a, b, c, d). First, the prevalence of
Plasmodium infections (P. vivax and P. falciparum) was
estimated, using the following equations:
Pt ¼ at þ ctN ;Ppv ¼
apv þ cpv
N
;Ppf ¼ apf þ cpfN
where a + c is the number of individuals carrying the
malaria parasite, and t = all parasites, pv = P. vivax, and
pf = P. falciparum. N is the representative sample. The
prevalences (Pt, Ppv, Ppf ) represented estimates of the
magnitude of the malarial subclinical infections on the
blood donor population. Then the PR was estimated,
giving a measure of the prevalence of subclinical malar-
ial infections in the exposed group in relation to the
non-exposed group, using the following equation:
PRt;pv;pf ¼
at;pv;pf
at;pv;pfþbt;pv;pf
ct;pv;pf
ct;pv;pfþdt;pv;pf
where a = the number of subclinical malarial infections
in the exposed group; c = the number of subclinical malar-
ial infections in the non-exposed group; a + b = total ex-
posed individuals; c + d = total non-exposed individuals.
PR was estimated for each parasite, with t = all parasites,
pv = P. vivax, and pf = P. falciparum. If the presence of a
certain exposure factor (e.g., forest proximity) does not in-
crease the prevalence of subclinical malaria, the PR is ex-
pected to be 1; PR > 1 indicates a positive association
between exposure and prevalence; and a PR < 1 suggests
that the association is negative. A confidence interval of
95% was provided for each estimate of the PR. Additional
theoretical rationale for these procedures can be obtained
from Rothman [31].
The detected subclinical Plasmodium infection cases
were geo-referenced using resident address and routines
implemented in the R 3.0.0 programming environment
with the aid of the ggmap package [32]. With this rou-
tine, addresses in a specific format (e.g., “100 Winter
Avenue, Dream City NY”) were searched in the databases
of Google MapsTM. These searches returned geographic
coordinates (longitude and latitude) that were plotted over
a satellite imagery scenario provided by Google MapsTM.
Geo-referenced data were used to identify possible expla-
nations considering the observed pattern of geographic dis-
tributions of subclinical malarial infections.
Results
A total of 1,108 individuals were selected in the present
study. From this sample, 61 were exposed and had a
subclinical malaria infection; 439 were exposed and did
not have a subclinical malaria infection; 23 were non-
exposed and had a subclinical malaria infection; and 585
were non-exposed and did not have a subclinical in-
fection (Table 1). The overall prevalence of subclinical
malarial infections among blood donors was 7.58 (%);
prevalence among exposed individuals was 12.20 (%)
and among non-exposed, it was 3.78 (%) (Table 1). The
PR was 3.23 and showed a positive statistically significant
association between exposure and subclinical malarial in-
fection (CI 95% = 2.03, 5.13) (Table 1).
Of the subclinical malarial infections (84), 57 were
P. falciparum, 25 were P. vivax, and two were mixed
(P. vivax and P. falciparum). Considering only P. fal-
ciparum subclinical infections, 53 blood donors of the ex-
posed group were positive for subclinical infection, 447
Table 1 Distribution of individual blood donors according
to exposure status and subclinical malarial infections in a
cross-sectional study design, São Paulo State, Brazil, Aug
2008–Mar 2010
Disease (+)* Disease (−) Total Prevalence**
Exposed (+) 61 439 500 12.20
Exposed (−) 23 585 608 3.78
Total 84 1,024 1,108 7.58
*In each group (exposed and non-exposed), 1 subject was infected by
both parasites.
**Cases per 100 population units.
Prevalence ratio (95% CI) = 3.23 (2.03, 5.13).
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were exposed and did not have any evidence of infec-
tion, 4 individuals of the non-exposed group tested posi-
tive, and 604 tested negative for infection (Table 2). The
total prevalence of subclinical P. falciparum infections in
blood donors was 5.14 (%); the prevalence among exposed
individuals was 10.60 (%); and among non-exposed, it was
0.66 (%) (Table 2). The prevalence ratio was 16.11 and
showed a positive, statistically significant association be-
tween exposure and subclinical P. falciparum infection
(CI 95% = 5.87, 44.21) (Table 2).
Considering the analysis of Plasmodium vivax sub-
clinical infections, seven exposed participants had a
subclinical infection, 493 were exposed without subclin-
ical infection, 18 non-exposed had subclinical infection,
and 590 non-exposed did not have subclinical infection
(Table 3). The total prevalence of subclinical P. vivax in-
fection among blood donors was 2.26 (%); prevalence
among exposed individuals was 1.40 (%), and among
non-exposed, it was 2.96 (%) (Table 3). The PR was 0.47
and showed a negative statistically non-significant associ-
ation between exposure and subclinical P. vivax infection
(CI 95% = 0.2, 1.12) (Table 3).
The 18 individuals with P. vivax subclinical infection
in the non-exposed group (Table 3) were geo-referenced.
These data showed that the majority of participants lived
in residences near the forest fringes (Figure 1A), al-
though these residences were in an urban area, i.e., the
São Paulo Metropolitan Region. Residents infected with
P. falciparum in the exposed region (Atlantic Forest)
were from the mountains (mainly in the Juquitiba and
São Lourenço da Serra municipalities). In both munici-
palities, forest cover is greater than 50%, and landscape
fragmentation provides high levels of interaction be-
tween the forest and the urban, anthropogenic environ-
ment (Figure 2B). Individuals infected with P. vivax in
the exposed region were from the coastal region of the
Peruíbe (Figure 2C) and São Sebastião (Figure 2D) mu-
nicipalities. These individuals inhabit houses located at
the frontier of the Atlantic Forest and the urban land-
scape, which form a mosaic of human-modified and nat-
ural environments that facilitate contact between humans
and sylvatic mosquitoes (Figures 2C and D).
Discussion
Despite control and prevention measures, malaria has
not been eliminated from non-endemic areas in south-
eastern Brazil. Autochthonous cases have been identified
in several regions [33-35], and human malaria is pre-
dominantly caused by P. vivax and its variants [36,37].
Subclinical Plasmodium infections have been considered
rare in Brazil; however, they have been detected and
identified in endemic regions [38]. A retrospective ana-
lysis of human malaria in the State of São Paulo from
1985–2006 found 83 cases, four of which were subclin-
ical infections [12]. Other studies have shown a low
parasitaemia rate in humans who inhabit areas within
the Atlantic Forest, with cases caused by P. vivax and
P. malariae [36].
Recently, molecular tools have been employed to detect
Plasmodium infection in human blood. Although PCR
techniques do not represent a rapid test for malaria diag-
nosis, they allow detection of as little as 0.5–1 parasite/μL
blood, making them 20 times more sensitive than thick
blood smear microscopic examination [30]. PCR methods
are also more sensitive in verifying mixed infections [39].
Additionally, real-time PCR allows pathogen quantifica-
tion, reduces the risk of cross-contamination, provides ac-
curate results [40], and identifies subclinical infections in
humans [37] that might otherwise remain undetected by
routine tests for malaria. Consequently, the new tech-
nology reveals a prevalence of subclinical infections in
humans that is higher than previously thought [41].
Human reservoirs can maintain transmission in areas
of low, moderate, or high endemicity because they can
infect mosquitoes [42]. Despite the role of subclinical
infection in maintaining malaria transmission, little is
known about the factors that determine its occurrence
and whether it is associated with human protective im-
mune responses [41].
Blood transfusion is an important intervention in hos-
pitals and health centres, but it also represents a route
for transmission of parasites and pathogens that circu-
late in the blood, such as HIV, human Plasmodium, vi-
ruses, and others [43]. Consequently, several measures are
being taken to improve blood recipient safety, including
Table 2 Distribution of individual blood donors according
to exposure status and P. falciparum subclinical infections
in a cross-sectional study design, São Paulo State, Brazil,
Aug 2008–Mar 2010
Disease (+) Disease (−) Total Prevalence*
Exposed (+) 53 447 500 10.60
Exposed (−) 4 604 608 0.66
Total 57 1,051 1,108 5.14
*Cases per 100 population units.
Prevalence ratio (95% CI) = 16.11 (5.87, 44.21).
Table 3 Distribution of individuals blood donors according
to exposure status and P. vivax subclinical infections in a
cross-sectional study design, São Paulo State, Brazil, Aug
2008–Mar 2010
Disease (+) Disease (−) Total Prevalence*
Exposed (+) 7 493 500 1.40
Exposed (−) 18 590 608 2.96
Total 25 1,083 1,108 2.26
*Cases per 100 population units.
Prevalence ratio (95% CI) = 0.47 (0.2, 1.12).
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high-sensitivity screening tests. Considering only Plasmo-
dium, after the collection of the blood, the parasite can sur-
vive for at least one week at 4°C, as well as in frozen
erythrocytes [44]. Plasmodium transmission by transfusion
usually occurs through whole blood and red blood cells
and may occur less frequently through platelet concen-
trates, white blood cells, cryoprecipitate, and fresh frozen
plasma [18,45]. The blood bank is therefore an important
target for controlling undesirable Plasmodium transmis-
sion in endemic [38,46] and non-endemic regions [43,47].
Here, subclinical malarial infections were detected from
blood donors in the most important centre of public
healthcare in the State of São Paulo. The presence of P. fal-
ciparum among blood donors and the high prevalence of
these infections were not expected. In the present study,
each blood donor was interviewed and denied having been
in malaria endemic regions. Consequently, it is plausible to
assume that all subclinical infections were autochthonous.
It is noteworthy that all individuals reported here would be
accepted for blood donation using the current protocol
adopted in blood transfusion centres in the State of São
Paulo, which includes a questionnaire and an interview to
detect history of exposure to malaria, both applied by a
qualified professional. Therefore, although the clinical im-
portance of the findings described here remains to be
investigated, the presence of asymptomatic Plasmodium
infection in blood donors in non-endemic areas should be
an important concern for medical services, health author-
ities, and blood recipient safety [14].
Plasmodium vivax and its variants as well as P. falcip-
arum and P. malariae circulate in non-endemic areas,
where they are responsible for only a few, mostly oli-
gosymptomatic cases of malaria annually [1]. Because
Plasmodium species can circulate in cycles that involve
humans with low parasitaemia and sylvatic mosqui-
toes, and likely in non-human primate reservoirs [48,49],
malaria can be maintained indefinitely in silent cycles with-
out the consequences of high-level epidemics. The esti-
mated PR of subclinical infection found in blood donors
in São Paulo clearly shows that P. falciparum is positively
associated with forested areas. Juquitiba (30,239 inhabi-
tants, 55.03 inhabitants/km2) and São Lourenço da Serra
Figure 2 Subclinical malarial infections geo-referenced. Point XY coordinates of the residence of positive individuals and the presence of
parasites. A) Presence of P. vivax subclinical infections in the São Paulo Metropolitan Region. B) Presence of P. falciparum subclinical infections in
the highlands of the Atlantic Forest (Juquitiba and São Lourenço da Serra). C) Presence of P. vivax subclinical infection in the coastal city of
Peruíbe. D) Presence of P. vivax subclinical infection in the beaches of Praia do Una (São Sebastião). Images are from GoogleMapsTM.
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(14,874 inhabitants, 75 inhabitants/km2) are primarily
rural locations embedded in a well-preserved and exten-
sively forested area on the slope of Serra do Mar, where
the vectors are mainly sylvatic mosquitoes from the sub-
genus Kerteszia of Anopheles. The human population
from these areas was here defined as the exposed popula-
tion whereas inhabitants of urban areas intercalated by
forest fragments formed the non-exposed population. In
the non-exposed population, the PR of P. vivax revealed
a positive (PR = 0.47; 95% CI, 0.2, 1.12) between the para-
site infection and urban inhabitants. However, this result
may arise from the fact that the residences of the blood
donors are situated in urban areas at the edge of forest
fragments. Consequently, the presence of P. vivax is
likely to be associated with forest fragments and involves
both Kerteszia and Nyssorhynchus species, or even other
Anopheles subgenera [48,50]. The evolution of transmis-
sion of Plasmodium species that cause malaria in humans
is a dynamic process that involves ecological, environmen-
tal, and climate factors as well as social, political, and eco-
nomic determinants. The high prevalence of Plasmodium
spp. subclinical infections in blood donors living either in
forested areas or urban regions intermixed with forest frag-
ments suggests that some evolutionary mechanisms are
modulating the virulence of P. falciparum and P. vivax in a
way that does not negatively affect survival of the parasite,
humans, mosquitoes, and non-human primates that seem
to be involved in malaria transmission in the Atlantic For-
est. The dynamics of human malaria transmission in the
Brazilian Amazon forest seems to involve similar evolu-
tionary mechanisms that lead to subclinical infections in
humans [42], and transmission cycles that involve humans
and other mosquito species as vectors (in addition to
An. darlingi) [51], and non-human primates, which were
recently found to be infected with P. falciparum [52]. In
the Atlantic Forest, Alouatta monkeys have been found
to be infected by P. vivax and P. malariae [49], along with
P. falciparum [48].
The scientific novelty and translational importance of
the present results are two-fold: 1) They could represent
a serious problem for the blood transfusion programme
in the State of São Paulo; and 2) they could be evidence
of evolutionary mechanisms of attenuation of malarial
symptoms in humans.
The translational importance of the first aspect is
obvious. Because some infected recipients may become
asymptomatic carriers and constitute a reservoir for par-
asites, maintaining their transmission, further investi-
gations are needed to better document the risk of
transfusion-transmitted malaria in these regions and to
establish whether a specific malarial infection test should
be considered for blood donors who live in or near the
Atlantic Forest. The second aspect is more subtle and
needs more data before being established as a paradigmatic
cornerstone for the evolution of malaria transmission
dynamics. In terms of clinical and economic viewpoints,
the Atlantic Forest’s dynamics of malaria transmission
could be a real-world example of symptomatic malaria
elimination.
Conclusions
The presence of subclinical P. falciparum and P. vivax
infection in healthy blood donors from São Paulo a non-
endemic region was described. This finding is a significant
concern in the context of transfusion biosafety. Some in-
fected recipients may be asymptomatic carriers, constitut-
ing a reservoir for parasites, maintaining their transmission
and increasing the risk of transfusion-transmitted malaria
in these regions. Additionally, prevalence ratio infection
values showed a positive association between forest envir-
onment and P. falciparum infection, which was linked to
residence in the mountain region of the Atlantic Forest
domain. Moreover, P. vivax seemed to be associated with
forest fragmentation because it was identified in residents
of cities in forest-surrounded areas. These results indicate
a link between the pathogen prevalence and the Atlantic
Forest environment.
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